Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Silence Therapeutics
Silence, its pipe line spans a super broad swath of therapeutic areas. It's more cardia, vascular and hemotologic disorders. That's the areas where we have initially focused for our own projects. But because we have these really great partnerships, ah, in addition to those riht, they come in to us and say, "We would like to explore in the areas that we're also interested in" So across the industries, the whole idea is this gold platform,. galnac liver oriented o orientation is really interesting for big parties and ourselves.
Transcript
Play full episode
